Literature DB >> 3540959

Molecular basis for group B beta-hemolytic streptococcal disease.

C G Hellerqvist, H Sundell, P Gettins.   

Abstract

Group B beta-hemolytic Streptococcus (GBS) is a major pathogen affecting newborns. We have investigated the molecular mechanism underlying the respiratory distress induced in sheep after intravenous injection of a toxin produced by this organism. The pathophysiological response is characterized by pulmonary hypertension, followed by granulocytopenia and increased pulmonary vascular permeability to protein. 31P NMR studies of GBS toxin and model components before and after reductive alkaline hydrolysis demonstrated that phosphodiester residues are an integral part of the GBS toxin. Reductive alkaline treatment cleaves phosphate esters from secondary and primary alcohols and renders GBS toxin nontoxic in the sheep model and inactive as a mediator of elastase release in vitro from isolated human granulocytes. We propose that the interaction of cellular receptors with mannosyl phosphodiester groups plays an essential role in the pathophysiological response to GBS toxin.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3540959      PMCID: PMC304139          DOI: 10.1073/pnas.84.1.51

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  14 in total

1.  Letter: Persistent group B Streptococcus bacteremia without clinical "sepsis" in infants.

Authors:  K B Roberts
Journal:  J Pediatr       Date:  1976-06       Impact factor: 4.406

2.  Group B streptococcal neonatal infection.

Authors:  K A Horn; W T Meyer; B C Wyrick; R A Zimmerman
Journal:  JAMA       Date:  1974-11-25       Impact factor: 56.272

3.  The group C 2 -type modification of the B-type lipopolysaccharide in a hybrid between salmonella groups B and C 2 .

Authors:  C G Hellerqvist; U Rudén; P H Mäkelä
Journal:  Eur J Biochem       Date:  1972-01-31

4.  A new method for the extraction of R lipopolysaccharides.

Authors:  C Galanos; O Lüderitz; O Westphal
Journal:  Eur J Biochem       Date:  1969-06

5.  Studies on group B beta-hemolytic Streptococcus. II. Effects on pulmonary hemodynamics and vascular permeability in unanesthetized sheep.

Authors:  J Rojas; R S Green; C G Hellerqvist; R Olegard; K L Brigham; M T Stahlman
Journal:  Pediatr Res       Date:  1981-06       Impact factor: 3.756

6.  Studies on group B beta-hemolytic Streptococcus. I. Isolation and partial characterization of an extracellular toxin.

Authors:  C G Hellerqvist; J Rojas; R S Green; S Sell; H Sundell; M T Stahlman
Journal:  Pediatr Res       Date:  1981-06       Impact factor: 3.756

7.  Complement activation and group B streptococcal infection in the newborn: similarities to endotoxin shock.

Authors:  L J Fenton; R C Strunk
Journal:  Pediatrics       Date:  1977-12       Impact factor: 7.124

8.  Antibiotic treatment of parturient women colonized with group B streptococci.

Authors:  R T Hall; W Barnes; L Krishnan; D J Harris; P G Rhodes; J Fayez; G L Miller
Journal:  Am J Obstet Gynecol       Date:  1976-03-15       Impact factor: 8.661

9.  Identification of a 2-aminotetrose in a lipid-soluble fraction of rat liver.

Authors:  D A Cumming; C G Hellerqvist; O Touster
Journal:  J Biol Chem       Date:  1981-08-10       Impact factor: 5.157

10.  Mediators of inflammation in leukocyte lysosomes. IX. Elastinolytic activity in granules of human polymorphonuclear leukocytes.

Authors:  A Janoff; J Scherer
Journal:  J Exp Med       Date:  1968-11-01       Impact factor: 14.307

View more
  3 in total

1.  New phenotypic typing scheme for group B streptococci.

Authors:  S R Heard; J A Mawn
Journal:  J Clin Pathol       Date:  1993-02       Impact factor: 3.411

2.  Group B Streptococcus and E. coli LPS-induced NO-dependent hyporesponsiveness to noradrenaline in isolated intrapulmonary arteries of neonatal piglets.

Authors:  E Villamor; F Pérez-Vizcaíno; T Ruiz; J C Leza; M Moro; J Tamargo
Journal:  Br J Pharmacol       Date:  1995-05       Impact factor: 8.739

3.  Antitumor effects of GBS toxin: a polysaccharide exotoxin from group B beta-hemolytic streptococcus.

Authors:  C G Hellerqvist; G B Thurman; D L Page; Y F Wang; B A Russell; C A Montgomery; H W Sundell
Journal:  J Cancer Res Clin Oncol       Date:  1993       Impact factor: 4.553

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.